EVIDENCE FOR INVOLVEMENT OF THE GROWTH-HORMONE RECEPTOR-ASSOCIATED TYROSINE KINASE IN ACTIONS OF GROWTH-HORMONE

被引:0
|
作者
CAMPBELL, GS
CHRISTIAN, LJ
CARTERSU, C
机构
[1] Department of Physiology, Univ. of Michigan Medical School, Ann Arbor, MI 48109-0622, United States
[2] National Institutes of Health
[3] Univ. of Michigan Medical School
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous observations have led to the speculation that activation of a growth hormone (GH) receptor-associated tyrosine kinase is an early, perhaps initiating, event in transmembrane signaling by GH. To test this hypothesis further, a Western blotting assay employing antibodies to phosphotyrosine was used to determine whether proteins other than the GH receptor might serve as substrates of the GH receptor-associated tyrosine kinase. The ability of inhibitors of the GH receptor-associated kinase to block actions of GH was also investigated. Over a physiologically relevant range of concentrations, GH was found to promote, in 3T3-F442A fibroblasts, rapid changes in the level of tyrosyl phosphorylation of more than 13 proteins. At the highest GH concentration employed (500 ng/ml), increased tyrosyl phosphorylation of two proteins, pp121 and pp97, was clearly visible at 1 min, the earliest time tested. Increased tyrosyl phosphorylation of a number of other proteins (pp250, pps160-180, pps140-160, pp130, pp90, pp75, pp45, pp42, pp39, and pp36) and decreased tyrosyl phosphorylation of a 140-kDa protein were apparent after 5-10 min of incubation with GH. Staurosporine, herbimycin A, and tyrphostin were identified as inhibitors of the GH receptor-associated kinase. When added to anti-GH antibody immunoprecipitates from GH-treated cells, they inhibited incorporation of P-32 from [gamma-P-32]ATP into tyrosyl residues in GH receptor complexes. When added to cells, all three inhibitors blocked all GH-dependent increases in tyrosyl phosphorylation of cellular proteins. Inhibitors of the GH receptor-associated tyrosine kinase also abolished GH-dependent activation of microtubule-associated protein (MAP) kinase. Consistent with these inhibitors inhibiting the GH receptor-associated tyrosine kinase, they had little or no effect on activation of MAP kinase by epidermal growth factor. In contrast, genistein and hydroxy-(2-naphthyl)-methylphosphonic acid, tyrosine kinase inhibitors lacking specificity for the GH receptor-associated kinase, decreased GH-dependent tyrosyl phosphorylation of only a subset of GH-responsive bands and partially blocked GH-dependent activation of MAP kinase. These data show that increased tyrosyl phosphorylation of specific cellular proteins is a very rapid response to the binding of GH by the cell and most likely involves multiple tyrosine kinases. Furthermore, inhibition of the GH receptor-associated tyrosine kinase blocks at least two actions of GH, the stimulation of tyrosyl phosphorylation of multiple proteins and MAP kinase activation. These results are consistent with the GH receptor-associated kinase playing an important, perhaps initiating, role in trans-membrane signaling by GH.
引用
收藏
页码:7427 / 7434
页数:8
相关论文
共 50 条
  • [31] EXOGENOUS GROWTH-HORMONE INHIBITS BOVINE BUT NOT MURINE PITUITARY GROWTH-HORMONE SECRETION INVITRO - EVIDENCE FOR A DIRECT FEEDBACK OF GROWTH-HORMONE ON THE PITUITARY
    ROSENTHAL, SM
    SILVERMAN, BL
    WEHRENBERG, WB
    NEUROENDOCRINOLOGY, 1991, 53 (06) : 597 - 600
  • [32] GROWTH AND GROWTH-HORMONE
    TUCHINDA, C
    ANGSUSINGHA, K
    PUNNAKANTA, L
    JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND, 1983, 66 (02): : 81 - 85
  • [33] GROWTH-HORMONE RECEPTOR AND BINDING-PROTEIN - MODULATORS OF CELLULAR RESPONSIVENESS TO GROWTH-HORMONE
    MAES, M
    MAITER, D
    MASSA, G
    KETELSLEGERS, JM
    ANNALES D ENDOCRINOLOGIE, 1995, 56 (04) : 253 - 258
  • [34] TREATMENT OF IDIOPATHIC GROWTH-HORMONE DEFICIENCY - COMPARISON OF GROWTH-HORMONE ALONE WITH GROWTH-HORMONE PLUS THYROXINE
    RANKE, M
    BIERICH, JR
    PEDIATRIC RESEARCH, 1978, 12 (11) : 1100 - 1100
  • [35] THE VALUE OF URINARY GROWTH-HORMONE DETERMINATION FOR ASSESSMENT OF GROWTH-HORMONE DEFICIENCY AND COMPLIANCE WITH GROWTH-HORMONE THERAPY
    PHILLIP, M
    CHALEW, SA
    STENE, MA
    KOWARSKI, AA
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (05): : 553 - 557
  • [36] GROWTH-HORMONE
    GRODECKA, B
    POSTEPY BIOCHEMII, 1975, 21 (02) : 213 - 229
  • [37] GROWTH-HORMONE
    CATCHPOLE, HR
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (07): : 652 - 652
  • [38] GROWTH HORMONE-DEPENDENT PHOSPHORYLATION OF TYROSINE-333 AND/OR TYROSINE-338 OF THE GROWTH-HORMONE RECEPTOR
    VANDERKUUR, JA
    WANG, XY
    ZHANG, LY
    ALLEVATO, G
    BILLESTRUP, N
    CARTERSU, C
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) : 21738 - 21744
  • [39] GROWTH-HORMONE
    GIRARD, F
    GOURMELEN, M
    SEMAINE DES HOPITAUX, 1977, 53 (33): : 639 - 642
  • [40] NO EVIDENCE FOR INCREASED GROWTH-HORMONE RESPONSES TO GROWTH-HORMONE RELEASING HORMONE IN PATIENTS WITH DIABETIC-RETINOPATHY
    PIETSCHMANN, P
    SCHERNTHANER, G
    PRSKAVEC, F
    GISINGER, C
    FREYLER, H
    DIABETES, 1987, 36 (02) : 159 - 162